Understanding the Diagnosis of Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is one of the most common functional gastrointestinal disorders encountered in clinical practice, affecting roughly 10% to 15% of the adult population globally [1]. Characterised by recurring abdominal pain, bloating, and altered bowel habits (diarrhoea, constipation, or alternating patterns), IBS can significantly impair quality of life [1, 2].
Because IBS is classified as a functional disorder, meaning there are no structural or anatomical abnormalities visible on routine scans or endoscopic procedures, patients often worry that their diagnosis is merely a "guess" or a "label" given when nothing else is found [2]. However, modern gastroenterology relies on validated clinical criteria and selective non-invasive testing to rule out organic diseases confidently and efficiently [1, 2].
Establishing the Clinical Diagnosis: The Rome IV and NICE Criteria
In the UK, general practitioners (GPs) follow guidance established by the National Institute for Health and Care Excellence (NICE CG61) alongside international standards like the Rome IV criteria [1, 2].
According to NICE guidelines, healthcare providers should evaluate a patient for IBS if they have experienced any of the following symptoms for at least 6 months:
- Abdominal pain or discomfort
- Bloating
- Change in bowel habit (frequency or consistency) [1]
A formal positive diagnosis of IBS should be considered only if the patient experiences abdominal pain or discomfort that is either relieved by defaecation or associated with an altered frequency or form of stool [1].
This must be accompanied by at least two of the following four symptoms:
1. Altered stool passage (straining, urgency, or a feeling of incomplete evacuation)
2. Abdominal bloating, distension, tension, or hardness
3. Symptoms exacerbated by eating
4. Passage of mucus in the stool [1]
The Rome IV criteria further refine this by specifying that abdominal pain must occur, on average, at least 1 day per week over the last 3 months, with symptom onset occurring at least 6 months prior to diagnosis [2].
Step 1: Evaluating "Red Flag" Symptoms
Before confirming an IBS diagnosis, clinicians ensure that there are no underlying "red flag" features suggesting organic conditions such as colorectal cancer, inflammatory bowel disease (IBD), or coeliac disease [1].
Red Flag Indicators Requiring Urgent Secondary Care Referral can include:
- Unexplained or unintentional weight loss [1]
- Rectal bleeding [1]
- Unexplained iron-deficiency anaemia [1]
- Abdominal masses or rectal masses detected on clinical examination [1]
- Family history of bowel or ovarian cancer [1]
- Onset of new, looser, or more frequent bowel movements persisting for more than 6 weeks in individuals aged over 60 [1]
Step 2: Diagnostic Investigations Used in the NHS
When no red flag indicators are present, the NHS primary care pathway utilises targeted initial laboratory investigations to systematically exclude organic gastrointestinal diseases that mimic IBS symptoms [1].
Full Blood Count (FBC)
Primary Diagnostic Objective: Measures red and white blood cells, haemoglobin, and platelets [1].
What the Test Helps To Rule Out: Iron-deficiency anaemia, occult gastrointestinal bleeding, or systemic infection [1].
C-Reactive Protein (CRP) & Erythrocyte Sedimentation Rate (ESR)
Primary Diagnostic Objective: Assesses systemic inflammatory markers in the blood [1].
What the Test Helps To Rule Out: Active systemic or intestinal inflammatory disorders (e.g., IBD) [1, 3].
Testing for Coeliac Disease (tTG-IgA)
Primary Diagnostic Objective: Detects tissue transglutaminase immunoglobulin A antibodies while on a gluten-containing diet [1, 4].
What the Test Helps To Rule Out: Coeliac Disease, an autoimmune response to gluten causing mucosal damage in the small intestine [4].
Faecal Calprotectin (Stool Test)
Primary Diagnostic Objective: Measures a protein released by neutrophils into the gut during active intestinal inflammation [3].
What the Test Helps To Rule Out: Inflammatory Bowel Disease (IBD), such as Crohn's disease or Ulcerative Colitis [3].
Thyroid Function Tests (TFTs)
Primary Diagnostic Objective: Evaluates thyroid-stimulating hormone (TSH) levels [1].
What the Test Helps To Rule Out: Hyperthyroidism (which can mimic IBS-D) or Hypothyroidism (which can mimic IBS-C) [1].
Secondary Considerations and Avoidance of Invasive Procedures
Under standard NICE guidelines, if a patient meets the clinical diagnostic criteria and all baseline laboratory and inflammatory screening results are normal, routine invasive procedures - such as colonoscopy, flexible sigmoidoscopy, abdominal ultrasound, or barium studies - are explicitly not recommended [1].
In specialised secondary care clinics, secondary causes of persistent diarrhoea-predominant symptoms (IBS-D) may occasionally be investigated if standard therapies fail:
- Bile Acid Malabsorption (BAM): Evaluated using a SeHCAT scan or an empirical trial of bile acid sequestrants in patients reporting chronic watery diarrhoea [1]
- Microscopic Colitis: Investigated via flexible sigmoidoscopy or colonoscopy with mucosal biopsies, typically considered in older patients presenting with severe, non-bloody watery diarrhoea [1]
Checking for gut health biomarkers at home
SELFCHECK has a range of digestive health self-testing kits to detect physiological biomarkers including coeliac disease (tTG IgA), Helicobacter pylori antibodies, and bowel screening faecal immunochemical tests (FIT), as well as a test for thyroid stimulating hormone (TSH) and a ferritin test for iron-deficiency anaemia. Self-testing kits are for preliminary screening for specific markers and the results, whether positive or negative, are meant to be discussed with an appropriate healthcare professional.
View our full range of self-testing kits giving results at home in minutes.
References
[1] National Institute for Health and Care Excellence (NICE). (2008; last updated 2017). Irritable bowel syndrome in adults: diagnosis and management (NICE Clinical Guideline CG61). https://www.nice.org.uk/guidance/cg61
[2] Lacy, B. E., & Patel, N. K. (2017). Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. Journal of Clinical Medicine, 6(11), 99. DOI: 10.3390/jcm6110099
[3] National Institute for Health and Care Excellence (NICE). (2013; reissued as HTG320 in 2017). Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (NICE HealthTech Guidance HTG320 / DG11). https://www.nice.org.uk/guidance/htg320
[4] National Institute for Health and Care Excellence (NICE). (2015). Coeliac disease: recognition, assessment and management (NICE Guideline NG20). https://www.nice.org.uk/guidance/ng20
Disclaimer: The information presented here is not intended as medical advice. Some of the content has been generated by A.I.
Always speak with your doctor in you are concerned about your symptoms.
Revised 8th October 2026